Advertisement
Screener

Nautilus Biotechnology, Inc. (NAUT) Effective Income Tax Rate Reconciliation, Tax Credit, Amount

Nautilus Biotechnology, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Amount

Nautilus Biotechnology, Inc. (NAUT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $2.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-02-26

  • Nautilus Biotechnology, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $2.09M, a 0.77% increase from fiscal 2023.
  • Nautilus Biotechnology, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $2.08M, a 20.41% decline from fiscal 2022.
  • Nautilus Biotechnology, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $2.61M, a 61.22% increase from fiscal 2021.
  • Nautilus Biotechnology, Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $1.62M, a 157.48% increase from fiscal 2020.
Period endEffective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month
2024-12-31$2.09M
10-K · filed 2026-02-26
2023-12-31$2.08M
10-K · filed 2025-02-27
2022-12-31$2.61M
10-K · filed 2024-02-28
2021-12-31$1.62M
10-K · filed 2023-02-23
2020-12-31$628.00K
10-K · filed 2022-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quanterix Corp (QTRX)United States$0.150B-1.65
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15